Literature DB >> 25212389

Synthesis of tumor-associated MUC1-glycopeptides and their multivalent presentation by functionalized gold colloids.

Isabella Tavernaro1, Sebastian Hartmann, Laura Sommer, Heike Hausmann, Christian Rohner, Martin Ruehl, Anja Hoffmann-Roeder, Sabine Schlecht.   

Abstract

The mucin MUC1 is a glycoprotein involved in fundamental biological processes, which can be found over-expressed and with a distinctly altered glycan pattern on epithelial tumor cells; thus it is a promising target structure in the quest for effective carbohydrate-based cancer vaccines and immunotherapeutics. Natural glycopeptide antigens indicate only a low immunogenicity and a T-cell independent immune response; however, this major drawback can be overcome by coupling of glycopeptide antigens multivalently to immunostimulating carrier platforms. In particular, gold nanoparticles are well suited as templates for the multivalent presentation of glycopeptide antigens, due to their remarkably high surface-to-volume ratio in combination with their high biostability. In this work the synthesis of novel MUC1-glycopeptide antigens and their coupling to gold nanoparticles of different sizes are presented. In addition, the development of a new dot-blot immunoassay to test the potential antigen-antibody binding is introduced.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25212389     DOI: 10.1039/c4ob01339e

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  11 in total

1.  Solid-phase synthesis of D-fructose-derived Heyns peptides utilizing Nα-Fmoc-Lysin[Nε-(2-deoxy-D-glucos-2-yl),Nε-Boc]-OH as building block.

Authors:  Sebastian Schmutzler; Daniel Knappe; Andreas Marx; Ralf Hoffmann
Journal:  Amino Acids       Date:  2021-05-02       Impact factor: 3.520

Review 2.  CNS active O-linked glycopeptides.

Authors:  Evan M Jones; Robin Polt
Journal:  Front Chem       Date:  2015-06-24       Impact factor: 5.221

Review 3.  Recent Advances in Subunit Vaccine Carriers.

Authors:  Abhishek Vartak; Steven J Sucheck
Journal:  Vaccines (Basel)       Date:  2016-04-19

4.  Immunological properties of gold nanoparticles.

Authors:  Lev A Dykman; Nikolai G Khlebtsov
Journal:  Chem Sci       Date:  2016-11-16       Impact factor: 9.825

Review 5.  Glyco-gold nanoparticles: synthesis and applications.

Authors:  Federica Compostella; Olimpia Pitirollo; Alessandro Silvestri; Laura Polito
Journal:  Beilstein J Org Chem       Date:  2017-05-24       Impact factor: 2.883

6.  Design, Synthesis, and Biological Evaluations of Asymmetric Bow-Tie PAMAM Dendrimer-Based Conjugates for Tumor-Targeted Drug Delivery.

Authors:  Tao Wang; Yaozhong Zhang; Longfei Wei; Yuhan G Teng; Tadashi Honda; Iwao Ojima
Journal:  ACS Omega       Date:  2018-04-03

Review 7.  Nanoparticles to Improve the Efficacy of Peptide-Based Cancer Vaccines.

Authors:  Anna Lucia Tornesello; Maria Tagliamonte; Maria Lina Tornesello; Franco M Buonaguro; Luigi Buonaguro
Journal:  Cancers (Basel)       Date:  2020-04-23       Impact factor: 6.639

Review 8.  Applications of Gold Nanoparticles in Nanomedicine: Recent Advances in Vaccines.

Authors:  Sónia Alexandra Correia Carabineiro
Journal:  Molecules       Date:  2017-05-22       Impact factor: 4.411

9.  A Tumor-Selective Monoclonal Antibody from Immunization with a Tumor-Associated Mucin Glycopeptide.

Authors:  Kevin R Trabbic; Kaitlyn Whalen; Karin Abarca-Heideman; Li Xia; J Sebastian Temme; Elijah F Edmondson; Jeffrey C Gildersleeve; Joseph J Barchi
Journal:  Sci Rep       Date:  2019-04-05       Impact factor: 4.379

10.  Improving the Switching Capacity of Glyco-Self-Assembled Monolayers on Au(111).

Authors:  Ellen Fast; Alexander Schlimm; Irene Lautenschläger; Kai Uwe Clausen; Thomas Strunskus; Carina Spormann; Thisbe K Lindhorst; Felix Tuczek
Journal:  Chemistry       Date:  2019-12-10       Impact factor: 5.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.